組織切片市場規模、佔有率和成長分析：按產品、技術、應用、最終用戶和地區分類 - 產業預測，2024-2031 年

2022年組織切片市場規模預計為16.8億美元，從2023年的18.6億美元成長到2031年的42.3億美元，預計複合年成長率為10.80%。

組織切片市場在醫療保健和生命科學領域佔據重要地位，為研究、診斷和治療提供重要支持。本概述提供了對塑造市場的主要趨勢、市場成長促進因素和挑戰的全面見解。組織切片是指將組織樣本精確分割成薄片以供顯微鏡檢查，在組織病理學、分子生物學、藥物發現和臨床診斷等應用中發揮基礎作用。市場擴張的主要驅動力是癌症和神經系統疾病等慢性疾病盛行率的上升，病理學家和研究人員對探索疾病機制、評估治療效果和科學研究的需求越來越大。 。技術進步，特別是自動化高通量系統，透過提高效率、準確性和可重複性以及最大限度地減少診斷和研究錯誤，改變了組織切片的實用性。此外，對個人化醫療和精確診斷的日益重視進一步強調了先進組織切片技術提供的詳細組織分析的重要性。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 監管環境
• 關鍵成功因素
• 價值鏈分析
• 市場吸引力指數
• 競爭程度
• 主要投資機會
• 生態系繪圖

組織切片市場：依產品

• 市場概況
• 裝置
  • 旋轉式切片機
  • 滑動切片機
  • 超薄切片機
  • 低溫恒溫器機
  • 其他
• 配件/消耗品
• 服務

組織切片市場：依技術分類

• 市場概況
• 自動的
• 半自動
• 手動的

組織切片製備市場：依應用分類

• 市場概況
• 診斷
• 研究

組織切片市場：依最終使用者分類

• 市場概況
• 醫院
• 診所
• 診斷實驗室
• 研究中心

組織切片製備市場規模：依地區分類

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Leica Biosystems（USA）
• Thermo Fisher Scientific Inc.（USA）
• Sakura Finetek USA, Inc.（USA）
• Danaher Corporation（USA）
• Agilent Technologies, Inc.（USA）
• Merck KGaA（Germany）
• Roche Diagnostics（Switzerland）
• CellPath Ltd（UK）
• Gilson Incorporated（USA）
• RMC Boeckeler（USA）
• Slee Medical GmbH（Germany）
• MEDITE GmbH（Germany）
• Jinhua YIDI Medical Appliance Co., Ltd.（China）
• Diapath SpA（Italy）
• Hacker Instruments & Industries Inc.（USA）
• Bright Instrument Company Ltd（UK）
• Boeckel+Co（GmbH+Co）KG（Germany）
• Jinhua Yidi Medical Appliance Co., Ltd.（China）
• MICROS Produktions-und Handelsgesellschaft mbH（Austria）
• Nanolytik GmbH（Germany）
• Microservice Srl（Italy）
• SLEE medical GmbH（Germany）
• Screen Holdings Co., Ltd.（Japan）
• REMI Group（India）
• Marienfeld Superior（Germany）

Tissue Sectioning Market size was valued at USD 1.68 billion in 2022 and is poised to grow from USD 1.86 billion in 2023 to USD 4.23 billion by 2031, growing at a CAGR of 10.80% during the forecast period (2024-2031).

The Tissue Sectioning Market holds significant importance within healthcare and life sciences, crucially supporting research, diagnostics, and medical treatments. This overview offers a comprehensive insight into the key trends, drivers of growth, and challenges shaping the market. Tissue sectioning entails the precise division of tissue samples into thin slices for microscopic examination, playing a fundamental role in applications spanning histopathology, molecular biology, drug discovery, and clinical diagnostics. A major catalyst for market expansion is the rising incidence of chronic diseases like cancer and neurological disorders, driving demand among pathologists and researchers who depend on tissue sectioning to explore disease mechanisms, assess treatment efficacy, and advance scientific understanding. Technological advancements, particularly automated and high-throughput systems, have transformed tissue sectioning practices by enhancing efficiency, accuracy, and reproducibility, thereby minimizing diagnostic and research errors. Furthermore, the increasing emphasis on personalized medicine and precision diagnostics further underscores the criticality of detailed tissue analysis provided by advanced tissue sectioning techniques, essential for tailored patient care strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Tissue Sectioning Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Tissue Sectioning Market Segmental Analysis

The Tissue Sectioning Market is segmented on the basis of product, technology, application, end-use and region. By product, the market is segmented into Instruments (Rotary Microtome, Sliding Microtome, Ultramicrotome, Cryostat microtome, others), Accessories & Consumables, Services. Based on technology, the market is segmented into automatic, semiautomatic, and manual. Based on application, the market is segmented into diagnosis and research. Based on end-use, the market is segmented into hospitals, clinics, diagnostic laboratories, and research centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Tissue Sectioning Market

The increasing incidence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders has significantly propelled the tissue sectioning market forward. Tissue sectioning plays a critical role in pathology and research by facilitating the diagnosis and comprehension of these ailments. With an aging population and a growing prevalence of chronic diseases, there has been a heightened demand for tissue sectioning equipment and services. Concurrently, technological advancements in tissue sectioning equipment and techniques have been pivotal. Enhanced automation, precision, and the development of advanced staining methods have markedly improved the efficiency and accuracy of tissue sectioning. These innovations not only bolster research and diagnostic capabilities but also streamline the procedural time and labor involved in tissue sectioning.

Restraints in the Tissue Sectioning Market

High equipment costs associated with tissue sectioning, particularly advanced automated systems, pose a significant barrier for smaller laboratories, clinics, and research institutions with limited budgets, restraining the adoption of this technology in resource-constrained settings. Additionally, stringent regulatory requirements for clinical diagnostics impose substantial time and financial burdens on manufacturers and laboratories, aiming to ensure accuracy and patient safety. These regulations, coupled with potential delays in approvals or changes, further hinder the growth of the tissue sectioning market by complicating product launches and limiting market access.

Market Trends of the Tissue Sectioning Market

Automation and digitization are transforming the tissue sectioning landscape, marking a significant trend in the market. This evolution is characterized by the widespread adoption of automated equipment like microtomes and cryostats, aimed at enhancing the precision and efficiency of tissue sectioning while minimizing the risk of cross-contamination. Moreover, the shift towards digitizing tissue sections facilitates easier storage, analysis, and sharing of samples through digital pathology systems and advanced image analysis software. In parallel, tissue sectioning's pivotal role spans across diverse domains such as medical research, pathology, and clinical diagnostics, responding to escalating demands in cancer research, neuroscience, drug development, and disease diagnosis. This trend is driven by ongoing advancements in genomics and proteomics, underscoring tissue sectioning's indispensable contribution to research and diagnostic applications, poised for continued growth in the foreseeable future.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Regulatory Landscape
• Key Success Factors
• Value Chain Analysis
• Market Attractiveness Index
• Degree of Competition
• Top Investment Pockets
• Ecosystem Mapping

Tissue Sectioning Market by Product

• Market Overview
• Instruments
  • Rotary Microtome
  • Sliding Microtome
  • Ultramicrotome
  • Cryostat microtome
  • Others
• Accessories & Consumables
• Services

Tissue Sectioning Market by Technology

• Market Overview
• Automatic
• Semiautomatic
• Manual

Tissue Sectioning Market by Application

• Market Overview
• Diagnosis
• Research

Tissue Sectioning Market by End User

• Market Overview
• Hospitals
• Clinics
• Diagnostic Laboratories
• Research Center

Gasoline Gensets Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Leica Biosystems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sakura Finetek USA, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CellPath Ltd (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilson Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RMC Boeckeler (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Slee Medical GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MEDITE GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jinhua YIDI Medical Appliance Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diapath S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hacker Instruments & Industries Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bright Instrument Company Ltd (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boeckel + Co (GmbH + Co) KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jinhua Yidi Medical Appliance Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MICROS Produktions- und Handelsgesellschaft m.b.H (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nanolytik GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microservice S.r.l. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SLEE medical GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Screen Holdings Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• REMI Group (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marienfeld Superior (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments